Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.53 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.50 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.50 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.48 |
| ▸ | OTC | P00480 | 1/20 | 0.48 |
| ▸ | RRM1 | P23921 | 1/20 | 0.45 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.45 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 3/20 | 0.43 |
| ▸ | NOS1 | P29475 | 3/20 | 0.43 |
| ▸ | NOS2 | P35228 | 3/20 | 0.43 |
| ▸ | ARG1 | P05089 | 3/20 | 0.41 |
| ▸ | ARG2 | P78540 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NPY4R | P50391 | 2/20 | 0.40 |
| ▸ | NPY1R | P25929 | 1/20 | 0.40 |
| ▸ | NPY2R | P49146 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6037862 | 1.00 | DPP7 (0.53) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL1768660 | 0.94 | DPP7 (0.49) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL22401386 | 0.94 | DPP7 (0.49) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL1769706 | 0.94 | DPP7 (0.49) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL1768651 | 0.94 | DPP7 (0.49) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| Arginine SCHEMBL5152371 | 0.94 | OTC (0.53) | OTCDDAH1GSRNOS3NOS1 | |
| Arginine SCHEMBL27550632 | 0.94 | OTC (0.53) | OTCDDAH1GSRNOS3NOS1 | |
| Arginine SCHEMBL8041512 | 0.92 | OTC (0.51) | OTCDDAH1GSRNOS3NOS1 | |
| Arginine SCHEMBL18301526 | 0.92 | OTC (0.51) | OTCDDAH1GSRNOS3NOS1 | |
| SCHEMBL23610947 | 0.92 | DPP7 (0.61) | DPP7GNAI3GNAO1GNAI1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060246104-A1 | Stable rgd peptidomimetic composition | MASSIA STEPHEN P | 2006-11-02 | — | — | US | claimed |
| WO-2004094457-A2 | STABLE RGD PEPTIDOMIMETIC COMPOSITION | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF, ARIZONA STATE UNIVERSITY (US) | 2004-11-04 | — | — | WO | claimed |
| US-20060246104-A1 | Stable rgd peptidomimetic composition | MASSIA STEPHEN P | 2006-11-02 | — | — | US | disclosed |
| US-20060246104-A1 | Stable rgd peptidomimetic composition | MASSIA STEPHEN P | 2006-11-02 | — | — | US | disclosed |
| WO-2004094457-A3 | STABLE RGD PEPTIDOMIMETIC COMPOSITION | UNIV ARIZONA (US) | 2005-06-02 | — | — | WO | disclosed |
| WO-2004094457-A2 | STABLE RGD PEPTIDOMIMETIC COMPOSITION | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF, ARIZONA STATE UNIVERSITY (US) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004094457-A2 | STABLE RGD PEPTIDOMIMETIC COMPOSITION | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF, ARIZONA STATE UNIVERSITY (US) | 2004-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246104-A1 | Stable rgd peptidomimetic composition | PLAUR, GALR2, GPR119 | DPP7 1898/4885GNAI3 155/4885GNAO1 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.